STOCK TITAN

iCAD to Participate at the 11th Annual LifeSci Partners Virtual Corporate Access Event

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

iCAD, a leader in medical technology, announced participation in the 11th Annual LifeSci Partners Corporate Access Event from January 5-7, 2022. The company's President and incoming CEO, Stacey Stevens, will join a panel titled “Med Tech / Digital Tools: What's the Mindset for 2022?” on January 5 at 2:00 pm ET. This virtual event will highlight key topics in life sciences and feature discussions with industry experts and company management teams. For more details, interested parties can register for the event online.

Positive
  • None.
Negative
  • None.

Company’s President and incoming CEO to participate in a panel discussion titled “Med Tech / Digital Tools: What's the Mindset for 2022?” on January 5, 2022 at 2:00 pm ET

NASHUA, N.H., Dec. 23, 2021 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it will attend the 11th Annual LifeSci Partners Corporate Access Event, being held virtually from January 5th to 7th, 2022.

Stacey Stevens, President and incoming CEO of iCAD, will participate in a panel discussion titled “Med Tech / Digital Tools: What's the Mindset for 2022?” on Wednesday, January 5th at 2:00 pm ET.

Please register for the event and confirm your interest in meeting with iCAD management here.

The LifeSci Corporate Access Event will feature innovative privately held and publicly traded biotechnology, medical technology, pharmaceutical, life sciences, and digital health companies from across the globe. The event will include meetings with company senior management teams and panel discussions featuring KOLs, CEOs, specialized investors, and healthcare experts, highlighting the most relevant topics impacting today’s life sciences industry.

About iCAD, Inc.
Headquartered in Nashua, NH, iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. For more information, visit www.icadmed.com.

Contact:
Media Inquiries:
Jessica Burns, iCAD
+1-201-423-4492
jburns@icadmed.com

Investor Relations:
Brian Ritchie, LifeSci Advisors
+ 1-212-915-2578
britchie@lifesciadvisors.com


FAQ

What is the date and time of iCAD's panel discussion at the LifeSci Partners Event?

iCAD's panel discussion will take place on January 5, 2022, at 2:00 pm ET.

Who will represent iCAD at the LifeSci Corporate Access Event?

Stacey Stevens, iCAD's President and incoming CEO, will represent the company.

What is the theme of the panel discussion featuring iCAD at the event?

The theme of the panel discussion is “Med Tech / Digital Tools: What's the Mindset for 2022?”

When does the 11th Annual LifeSci Partners Corporate Access Event start?

The event starts on January 5, 2022, and runs until January 7, 2022.

How can I register for the LifeSci Partners Corporate Access Event?

Interested individuals can register for the event by visiting the registration link provided in the press release.

Icad Inc

NASDAQ:ICAD

ICAD Rankings

ICAD Latest News

ICAD Stock Data

44.54M
26.54M
5.63%
26.69%
0.89%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
NASHUA